CD8A and neoplasm: Out of all groups, the most intensive tumor-infiltrating CD8+ T cells, Th1-like memory CD4+ T cells as well as Tfh-like memory CD4+ T in the LRT-8 days group have been found (Fig. 7e), resulting in much enhanced overall immune cell percentage (Fig. 7d), benefiting long-lasting therapeutic effects and immune memory protection.